Pharmaceuticals - Community Register

  

List of referrals for human medicinal products

Thiocolchicoside

Product name: Thiocolchicoside
Also marketed in the EU under the name(s): ADALGUR, Adalgur N, COLTHIOZID, Coltramyl, DECONTRIL, MIOREL, MIOREXIL, MIOTENS, MOVERIL, MUSCO-RIL, MUSCOFLEX, Muscoril, MYOPLEGE, RELIEF, Relmus, SCIOMIR, STRIALISIN, TERASIDE, THIOCOLCHICOSIDE ACTAVIS, THIOCOLCHICOSIDE ALMUS, THIOCOLCHICOSIDE ALTER, THIOCOLCHICOSIDE ARROW, THIOCOLCHICOSIDE BIOGARAN, THIOCOLCHICOSIDE CRISTERS, THIOCOLCHICOSIDE EG, THIOCOLCHICOSIDE MYLAN, THIOCOLCHICOSIDE RATIOPHARM, THIOCOLCHICOSIDE SANDOZ, THIOCOLCHICOSIDE TEVA, THIOCOLCHICOSIDE ZENTIVA, TIOCOLCHICOSIDE, TIOCOLCHICOSIDE ANGENERICO, TIOCOLCHICOSIDE EG, TIOCOLCHICOSIDE GERMED, TIOCOLCHICOSIDE MYLAN GENERICS, TIOCOLCHICOSIDE UNION HEALTH, TIOCOLCHICOSIDE ZENTIVA, Tiocolquicosido Arrowblue, Tiocolquicosido Generis, TIOSIDE
Active substance: thiocolchicoside
Indication: Adjuvant treatment of painful muscle contractures in acute spinal pathology in adults and adolescents from 16 years onwards.
Marketing Authorisation Holder: Not applicable

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
21/01/2014 Referral EMEA/H/A-31/1361 (2014)339 of 17/01/2014